Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study.

Pérez de Isla L, Alonso R, Muñiz-Grijalvo O, Díaz-Díaz JL, Zambón D, Miramontes JP, Fuentes F, Gómez de Diego JJ, González-Estrada A, Mata N, Saltijeral A, Barreiro M, Tomás M, de Andrés R, Argüeso R, Serrano Gotarredona MP, Navarro Herrero S, Perea Palazón RJ, de Caralt TM, Suárez de Centi LA, Zhilina S, Espejo Pérez S, Padró T, Mata P; SAFEHEART investigators.

J Clin Lipidol. 2018 Jul - Aug;12(4):948-957. doi: 10.1016/j.jacl.2018.04.003. Epub 2018 Apr 17.

PMID:
29753733
2.

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).

Pérez de Isla L, Alonso R, Mata N, Fernández-Pérez C, Muñiz O, Díaz-Díaz JL, Saltijeral A, Fuentes-Jiménez F, de Andrés R, Zambón D, Piedecausa M, Cepeda JM, Mauri M, Galiana J, Brea Á, Sanchez Muñoz-Torrero JF, Padró T, Argueso R, Miramontes-González JP, Badimón L, Santos RD, Watts GF, Mata P.

Circulation. 2017 May 30;135(22):2133-2144. doi: 10.1161/CIRCULATIONAHA.116.024541. Epub 2017 Mar 8.

PMID:
28275165
3.

Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.

Alonso R, Díaz-Díaz JL, Arrieta F, Fuentes-Jiménez F, de Andrés R, Saenz P, Ariceta G, Vidal-Pardo JI, Almagro F, Argueso R, Prieto-Matos P, Miramontes JP, Pintó X, Rodriguez-Urrego J, Perez de Isla L, Mata P.

J Clin Lipidol. 2016 Jul-Aug;10(4):953-961. doi: 10.1016/j.jacl.2016.04.006. Epub 2016 Apr 21.

PMID:
27578128
4.

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.

Perez de Isla L, Alonso R, Watts GF, Mata N, Saltijeral Cerezo A, Muñiz O, Fuentes F, Diaz-Diaz JL, de Andrés R, Zambón D, Rubio-Marin P, Barba-Romero MA, Saenz P, Sanchez Muñoz-Torrero JF, Martinez-Faedo C, Miramontes-Gonzalez JP, Badimón L, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2016 Mar 22;67(11):1278-85. doi: 10.1016/j.jacc.2016.01.008.

5.

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.

Fuentes F, Alcala-Diaz JF, Watts GF, Alonso R, Muñiz O, Díaz-Díaz JL, Mata N, Sanchez Muñoz-Torrero JF, Brea Á, Galiana J, Figueras R, Aguado R, Piedecausa M, Cepeda JM, Vidal JI, Rodríguez-Cantalejo F, López-Miranda J, Mata P; SAFEHEART Investigators.

Int J Cardiol. 2015 Dec 15;201:79-84. doi: 10.1016/j.ijcard.2015.07.107. Epub 2015 Aug 5.

PMID:
26296047
6.

[Familial combined hyperlipidemia: consensus document].

Mata P, Alonso R, Ruíz-Garcia A, Díaz-Díaz JL, González N, Gijón-Conde T, Martínez-Faedo C, Morón I, Arranz E, Aguado R, Argueso R, Perez de Isla L.

Semergen. 2014 Oct;40(7):374-80. doi: 10.1016/j.semerg.2014.07.007. Epub 2014 Aug 11. Spanish.

PMID:
25131181
7.

[Familial combined hyperlipidemia: consensus document].

Mata P, Alonso R, Ruíz-Garcia A, Díaz-Díaz JL, González N, Gijón-Conde T, Martínez-Faedo C, Morón I, Arranz E, Aguado R, Argueso R, Perez de Isla L.

Aten Primaria. 2014 Oct;46(8):440-6. doi: 10.1016/j.aprim.2014.04.013. Epub 2014 Jul 14. Spanish.

8.

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.

Alonso R, Andres E, Mata N, Fuentes-Jiménez F, Badimón L, López-Miranda J, Padró T, Muñiz O, Díaz-Díaz JL, Mauri M, Ordovás JM, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2014 May 20;63(19):1982-9. doi: 10.1016/j.jacc.2014.01.063. Epub 2014 Mar 13.

9.

Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain.

Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J; Galician Group for the Study of Toxic Multinodular Goitre, Araujo Vilar D, Argueso R, Barca O, Botana M, Cabezas-Agrícola JM, Catalina P, Dominguez Gerpe L, Fernandez T, Mato A, Nuño A, Penin M, Victoria B.

Eur J Endocrinol. 2008 Nov;159(5):623-31. doi: 10.1530/EJE-08-0313. Epub 2008 Aug 11.

PMID:
18694911
10.

Superficial collections of fluid tophaceous material as clinical presentation of anorexia nervosa.

Garcia-Porrua C, Canedo C, Argueso R, Gonzalez-Gay MA.

Ann Rheum Dis. 2005 Nov;64(11):1658-9. No abstract available.

11.

[Central diabetes insipidus secondary to infundibuloneurohypophysitis].

Isidro ML, Martínez A, Argüeso R, Cordido F.

An Med Interna. 1998 Dec;15(12):658-60. Spanish.

PMID:
9972603
12.

Amiodarone and thyroid function.

Isidro ML, Argüeso R, Cordido F.

Ann Intern Med. 1997 Oct 15;127(8 Pt 1):653. No abstract available.

PMID:
9341069
13.

MRI of mediastinal parathyroid cystic adenoma causing hyperparathyroidism.

Soler R, Bargiela A, Cordido F, Aguilera C, Argüeso R, Cao I.

J Comput Assist Tomogr. 1996 Jan-Feb;20(1):166-8. No abstract available.

PMID:
8576473

Supplemental Content

Loading ...
Support Center